Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients

類似資料

• Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients
  著者:: Kappelhoff, Bregt S, 等
  出版事項: (2005)
• Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients
  著者:: Crommentuyn, K M L, 等
  出版事項: (2005)
• Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
  著者:: de Maat, Monique M R, 等
  出版事項: (2002)
• Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients
  著者:: ter Heine, Rob, 等
  出版事項: (2010)
• Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer
  著者:: Koolen, Stijn L W, 等
  出版事項: (2010)